BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 29857221)

  • 1. Syntenin-targeted peptide blocker inhibits progression of cancer cells.
    Liu J; Qu J; Zhou W; Huang Y; Jia L; Huang X; Qian Z; Xia J; Yu Y
    Eur J Med Chem; 2018 Jun; 154():354-366. PubMed ID: 29857221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syntenin-syndecan binding requires syndecan-synteny and the co-operation of both PDZ domains of syntenin.
    Grootjans JJ; Reekmans G; Ceulemans H; David G
    J Biol Chem; 2000 Jun; 275(26):19933-41. PubMed ID: 10770943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the integrin effector kinase focal adhesion kinase in cancer cells is regulated by crosstalk between protein kinase Calpha and the PDZ adapter protein mda-9/Syntenin.
    Hwangbo C; Kim J; Lee JJ; Lee JH
    Cancer Res; 2010 Feb; 70(4):1645-55. PubMed ID: 20145126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syntenin: PDZ Protein Regulating Signaling Pathways and Cellular Functions.
    Shimada T; Yasuda S; Sugiura H; Yamagata K
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31454940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Src kinase activation is mandatory for MDA-9/syntenin-mediated activation of nuclear factor-kappaB.
    Boukerche H; Aissaoui H; Prévost C; Hirbec H; Das SK; Su ZZ; Sarkar D; Fisher PB
    Oncogene; 2010 May; 29(21):3054-66. PubMed ID: 20228839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tandem PDZ domains of syntenin promote cell invasion.
    Meerschaert K; Bruyneel E; De Wever O; Vanloo B; Boucherie C; Bracke M; Vandekerckhove J; Gettemans J
    Exp Cell Res; 2007 May; 313(9):1790-804. PubMed ID: 17451681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual Targeting of the PDZ1 and PDZ2 Domains of MDA-9/Syntenin Inhibits Melanoma Metastasis.
    Pradhan AK; Modi J; Maji S; Kumar A; Bhoopathi P; Mannangatti P; Guo C; Afosah DK; Mochel MC; Mukhopadhyay ND; Kirkwood JM; Wang XY; Desai UR; Sarkar D; Emdad L; Das SK; Fisher PB
    Mol Cancer Ther; 2023 Oct; 22(10):1115-1127. PubMed ID: 37721536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syntenin: a novel PDZ domain-containing scaffolding protein associated with human melanoma metastasis.
    Yang JB; McCarthy JB
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Apr; 32(2):204-12. PubMed ID: 17478924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MDA-9/syntenin is essential for factor VIIa-induced signaling, migration, and metastasis in melanoma cells.
    Aissaoui H; Prévost C; Boucharaba A; Sanhadji K; Bordet JC; Négrier C; Boukerche H
    J Biol Chem; 2015 Feb; 290(6):3333-48. PubMed ID: 25505176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The tandem PDZ protein Syntenin interacts with the aminoacyl tRNA synthetase complex in a lysyl-tRNA synthetase-dependent manner.
    Meerschaert K; Remue E; De Ganck A; Staes A; Boucherie C; Gevaert K; Vandekerckhove J; Kleiman L; Gettemans J
    J Proteome Res; 2008 Nov; 7(11):4962-73. PubMed ID: 18839981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of radiation-induced glioblastoma invasion by genetic and pharmacological targeting of MDA-9/Syntenin.
    Kegelman TP; Wu B; Das SK; Talukdar S; Beckta JM; Hu B; Emdad L; Valerie K; Sarkar D; Furnari FB; Cavenee WK; Wei J; Purves A; De SK; Pellecchia M; Fisher PB
    Proc Natl Acad Sci U S A; 2017 Jan; 114(2):370-375. PubMed ID: 28011764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A PDZ Protein MDA-9/Syntenin: As a Target for Cancer Therapy.
    Yu Y; Li S; Wang K; Wan X
    Comput Struct Biotechnol J; 2019; 17():136-141. PubMed ID: 30766662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PDZ tandem of human syntenin: crystal structure and functional properties.
    Kang BS; Cooper DR; Jelen F; Devedjiev Y; Derewenda U; Dauter Z; Otlewski J; Derewenda ZS
    Structure; 2003 Apr; 11(4):459-68. PubMed ID: 12679023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A High-Affinity Peptide Ligand Targeting Syntenin Inhibits Glioblastoma.
    Haugaard-Kedström LM; Clemmensen LS; Sereikaite V; Jin Z; Fernandes EFA; Wind B; Abalde-Gil F; Daberger J; Vistrup-Parry M; Aguilar-Morante D; Leblanc R; Egea-Jimenez AL; Albrigtsen M; Jensen KE; Jensen TMT; Ivarsson Y; Vincentelli R; Hamerlik P; Andersen JH; Zimmermann P; Lee W; Strømgaard K
    J Med Chem; 2021 Feb; 64(3):1423-1434. PubMed ID: 33502198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The binding of the PDZ tandem of syntenin to target proteins.
    Grembecka J; Cierpicki T; Devedjiev Y; Derewenda U; Kang BS; Bushweller JH; Derewenda ZS
    Biochemistry; 2006 Mar; 45(11):3674-83. PubMed ID: 16533050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MDA-9/Syntenin-Slug transcriptional complex promote epithelial-mesenchymal transition and invasion/metastasis in lung adenocarcinoma.
    Wang LK; Pan SH; Chang YL; Hung PF; Kao SH; Wang WL; Lin CW; Yang SC; Liang CH; Wu CT; Hsiao TH; Hong TM; Yang PC
    Oncotarget; 2016 Jan; 7(1):386-401. PubMed ID: 26561205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fragment-based drug design targeting syntenin PDZ2 domain involved in exosomal release and tumour spread.
    Garcia M; Hoffer L; Leblanc R; Benmansour F; Feracci M; Derviaux C; Egea-Jimenez AL; Roche P; Zimmermann P; Morelli X; Barral K
    Eur J Med Chem; 2021 Nov; 223():113601. PubMed ID: 34153575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic peptide phage display uncovers novel interactions of the PDZ1-2 supramodule of syntenin.
    Garrido-Urbani S; Garg P; Ghossoub R; Arnold R; Lembo F; Sundell GN; Kim PM; Lopez M; Zimmermann P; Sidhu SS; Ivarsson Y
    FEBS Lett; 2016 Jan; 590(1):3-12. PubMed ID: 26787460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New structural insight of C-terminal region of Syntenin-1, enhancing the molecular dimerization and inhibitory function related on Syndecan-4 signaling.
    Choi Y; Yun JH; Yoo J; Lee I; Kim H; Son HN; Kim IS; Yoon HS; Zimmermann P; Couchman JR; Cho HS; Oh ES; Lee W
    Sci Rep; 2016 Nov; 6():36818. PubMed ID: 27830760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological inhibition of MDA-9/Syntenin blocks breast cancer metastasis through suppression of IL-1β.
    Pradhan AK; Maji S; Bhoopathi P; Talukdar S; Mannangatti P; Guo C; Wang XY; Cartagena LC; Idowu M; Landry JW; Sarkar D; Emdad L; Cavenee WK; Das SK; Fisher PB
    Proc Natl Acad Sci U S A; 2021 May; 118(21):. PubMed ID: 34016751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.